Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine
Aim. To study the effect of ivabradine and bisoprolol on cardiac hemodynamics and diastolic remodeling in gout patients with coronary artery disease and hypertension and without left ventricular systolic dysfunction.Material and methods. The open randomized parallel clinical trial of 35 men with int...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
«FIRMA «SILICEA» LLC
2020-08-01
|
| Edice: | Российский кардиологический журнал |
| Témata: | |
| On-line přístup: | https://russjcardiol.elpub.ru/jour/article/view/3980 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|